Nonrestricted cytotoxicity mediated by interleukin 2-expanded leukocytes is inhibited by anti-LFA-1 monoclonal antibodies (MoAb) but potentiated by anti-CD3 MoAb
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 110 (2) , 282-293
- https://doi.org/10.1016/0008-8749(87)90123-7
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytesHuman Immunology, 1987
- The T4 molecule: function and structureImmunology Today, 1986
- Evidence for three types of human cytotoxic lymphocyteImmunology Today, 1986
- A speculative view of the multicomponent nature of T cell antigen recognitionCell, 1986
- Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies.The Journal of Experimental Medicine, 1986
- Induction of the expression of HLA class I antigens on K562 by interferons and sodium butyrateHuman Immunology, 1985
- Effects of monoclonal antibodies to the a and β chains of the human lymphocyte function‐associated (H‐LFA‐1) antigen on T lymphocyte functionsEuropean Journal of Immunology, 1985
- A human lymphocyte‐associated antigen involved in cell‐mediated lympholysisEuropean Journal of Immunology, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Assay of the Infectivity of Epstein-Barr Virus by Transformation of Human Leucocytes in vitroJournal of General Virology, 1972